However, when the Fc region of h128-3 is modified at the N297 residue to reduce FcγR-mediated effector functions, the antibody is not able to optimally induce these phenotypes in FcγRhigh monocytic AML xenograft mouse models [3, 5]. This evidence concerns the gene FCGR2A and acute myeloid leukemia.